Omeros Corporation (OMER)
Add to Watchlists Create an AlertOmeros Corporation Current Ratio:
2.651 for Dec. 31, 2012Omeros Corporation Historical Current Ratio Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 2.651 |
| Sept. 30, 2012 | 1.441 |
| June 30, 2012 | 0.4939 |
| March 31, 2012 | 1.051 |
| Dec. 31, 2011 | 1.367 |
| Sept. 30, 2011 | 2.140 |
| June 30, 2011 | 2.766 |
| March 31, 2011 | 3.014 |
| Dec. 31, 2010 | 2.756 |
| Sept. 30, 2010 | 6.612 |
| June 30, 2010 | 4.255 |
| March 31, 2010 | 5.115 |
| Dec. 31, 2009 | 5.470 |
| Sept. 30, 2009 | 0.4137 |
| June 30, 2009 | 0.4788 |
| March 31, 2009 | |
| Dec. 31, 2008 | 0.8691 |
About Current Ratio
The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.
A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.
Other similar solvency ratios include :
Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
Learn More
OMER Current Ratio Benchmarks
| Companies | |
|---|---|
| Alexion Pharmaceuticals | 5.241 |
| Targacept | 21.12 |
| Regeneron Pharmaceuticals | 6.627 |
OMER Current Ratio Rankings
| Overall |
77th percentile 1765 of 8009 |
| Sector |
50th percentile 340 of 687 in Healthcare |
| Industry |
39th percentile 151 of 248 in Biotechnology |
OMER Current Ratio Range, Past 5 Years
| Minimum | 0.4137 | Sep 2009 |
| Maximum | 6.612 | Sep 2010 |
| Average | 2.556 |